Business Standard

China's Covid-19 vaccine shows promising results in early trials: Report

The trial was conducted by researchers at several laboratories and included 108 participants aged 18-60

hospital, beds, patients, doctors, nurses, health care, health workers, coronavirus, testing, vaccine
Premium

According to the latest data from Johns Hopkins University, the number of coronavirus cases worldwide has gone up to 5,209,266

ANI Beijing
Days after US drugmaker Moderna announced that Phase-I trial of its Covid-19 vaccine had shown positive results, researchers on Friday reported that a vaccine developed in China appeared to be safe and might protect people from the deadly virus.

According to a report in The New York Times citing early-stage trial, published in online journal Lancet, those who received a single dose of the vaccine produced certain immune cells, called T cells, within two weeks, while the antibodies needed for immunity peaked at 28 days after the inoculation.

The trial was conducted by researchers at several laboratories and included 108 participants

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: May 23 2020 | 10:41 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com